Posts Tagged ‘pharmaceutical’

Now that August is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in July – they’re ranked in order of popularity, with number one being the most viewed piece. When Do Companies Have To […]

In August of last year, I wrote a blog piece that discusses the possibility of GlaxoSmithKline (GSK) being one of the first pharmaceutical companies to use Apple’s ResearchKit. It appears that possibility has become reality. According to Bloomberg, the global pharma company will be leveraging a mobile app they created on ResearchKit to obtain information […]

The introduction of Identification of Medicinal Products (IDMP), as developed by the International Organization for Standardization (ISO), marks the next phase of evolution for the European drug dictionary project under Article 57. The European Medicines Agency (EMA) will issue guidance based on five documents published by the ISO, which will require life sciences companies to […]

Since the introduction of SharePoint 2016, the industry has been buzzing about how much easier and better digital collaboration has become, especially between partner companies. Here’s an example of how two large pharmaceutical companies are using SharePoint as a collaboration space for their joint drug development projects: Each organization had its own validated electronic document […]

There’s been a lot of talk recently about SharePoint 2016. This latest version is especially appealing to life sciences companies because it supports the flexibility of a hybrid on-site/cloud implementation. That means that organizations who aren’t quite ready to fully embrace the cloud have the power to host certain features in-house behind their firewall and […]

Now that June is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in May – they’re ranked in order of popularity, with number one being the most viewed piece. Gartner’s List Of 5 Cool Vendors […]

I came across an article that celebrated Genentech’s 40 years in business with a few fun facts and stories about the biotechnology pioneer: Founded on April 7, 1976 The name Genentech stems from GENetic ENgineering TECHnology The company was founded with a $1,000 investment in 1976 by Robert Swanson, a venture capitalist, and Herbert Boyer, […]

If there’s one list that gets a lot of touch attention in life sciences, it’s Gartner’s Cool Vendors in Life Sciences. While the name of the list helps grab attention on its own, the companies it features are typically just as interesting. This year’s list happens to carry a few companies that we’ve blogged about, […]

In 2015, companies in all industries experienced data security breaches. From Anthem, one of the nation’s leading health benefits companies, to the UCLA Health System, all the way to Hzone, a matchmaking mobile application for HIV positive singles, no company was safe from a data breach. Increasing data privacy and security is a trend that […]

  Demographics in clinical trials have always been scrutinized by the medical community and the public. Are various races, ethnicities, sexes, and ages fairly represented in trials? Does one segment respond better or worse than another to a particular treatment? These questions and more are being answered in the Drug Trials Snapshots section of the […]

  At the end of 2015, Austin Frakt, a health economist, researcher, and contributor to The New York Times’ The Upshot, wrote about the life sciences industry’s lack of interest in developing medicines that prevent cancer. 

  As we mentioned in our life sciences trends guide for 2016, patient recruitment is a constant challenge that needs to be confronted head-on with innovative tactics and technology. The mere fact that only 5% of cancer patients ever enroll in a trial is simply unacceptable, considering how connected we are in the digital era.